Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1370, 2003-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Natalizumab maintains response in Crohn's disease
Inpharma, Vol. 1, Iss. 1458, 2004-01 ,pp. :
Access to resources
Recommend
Natalizumab shows potential in the treatment of Crohn's disease
Inpharma, Vol. 1, Iss. 1542, 2006-01 ,pp. :
Leflunomide demonstrates clinical improvement in Crohn's disease
Inpharma, Vol. 1, Iss. 1407, 2003-01 ,pp. :
Infliximab and etanercept: basis of efficacy in Crohn's disease
Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. :